NCT03154840View on ClinicalTrials.gov

Relative Bioavailability Among Different Eutropin Formulations

PHASE1UnknownINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 2017

Primary Completion Date

July 10, 2017

Study Completion Date

November 30, 2017

Conditions

Relative Bioavailability

Interventions

DRUG

Eutropin 4IU, Eutropin AQ 12IU, Eutropin Pen 36IU

Investigate the Relative Bioavailability among Different Eutropin Formulations

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LG Chem

INDUSTRY

NCT03154840 - Relative Bioavailability Among Different Eutropin Formulations | Biotech Hunter | Biotech Hunter